Dendritic cell-activated cytokine-induced killer cell-mediated immunotherapy is safe and effective for cancer patients >65 years old.

Abstract:

:Individuals >65 years old account for a large proportion of cancer patients, and usually have poor prognoses due to relative weaker physiological function and lower drug tolerance. To characterize the efficacy and safety of dendritic cell (DC)-activated cytokine-induced killer cell (CIK)-mediated treatment, and develop an adoptive immunotherapy for cancer patients >65 years old, a retrospective study was performed in 58 cancer sufferers who received 1-4 cycles of DC-activated CIK (DC-CIK) treatment and evaluated the response (tumor remission rate) and toxicity (side effects to the treatment). The present results showed that DCs and CIKs could be expanded rapidly in vitro, and following co-culture with DCs, the population of cluster of differentiation (CD) 3+, CD3+CD4+, CD3+CD8+ and CD3+CD56+ CIKs was significantly increased compared to CIKs without DC activation (P=0.044). In addition, DC-CIK infusion produced marked clinical outcomes, resulting in an objective remission rate, overall clinical benefit rate and Karnofsky performance status of 44.83, 75.86 and 87.28±5.46%, respectively, which was significantly improved compared with prior to treatment (P<0.05). Additionally, subsequent to two cycles of this immunotherapy, several tumor marker expression levels declined, returning to the normal range. The proportion of CD3+CD4+ (P=0.017) and CD3+CD8+ (P=0.023) lymphocytes, and the population of CD4/CD8 cells (P=0.024) were also increased. In conclusion, the present study suggests that the immunotherapy mediated by DC-CIK is safe and effective for cancer patients aged >65 years.

journal_name

Oncol Lett

journal_title

Oncology letters

authors

Liu Y,Liu H,Liu H,He P,Li J,Liu X,Chen L,Wang M,Xi J,Wang H,Zhang H,Zhu Y,Zhu W,Ning J,Guo C,Sun C,Zhang M

doi

10.3892/ol.2016.5337

subject

Has Abstract

pub_date

2016-12-01 00:00:00

pages

5205-5210

issue

6

eissn

1792-1074

issn

1792-1082

pii

OL-0-0-5337

journal_volume

12

pub_type

杂志文章
  • Expression of connexin 32 and connexin 43 in acute myeloid leukemia and their roles in proliferation.

    abstract::Connexins (Cxs), a conserved family of trans-membrane proteins, function in the organization of cell-cell communicatin via gap junctions in multicellular organisms. However, the role of Cxs in acute myeloid leukemia (AML) is poorly understood. In this study, we investigated the relationship between cell proliferation ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2012.884

    authors: Yi S,Chen Y,Wen L,Yang L,Cui G

    更新日期:2012-11-01 00:00:00

  • Bladder cancer in a young patient: Undiscovered risk factors.

    abstract::Bladder cancer is one of the most common forms of malignancies involving the urinary system and multiple risk factors have been associated with its etiology. The most common of which include cigarette smoking and various occupational or chemical exposures. It is usually diagnosed in older individuals with an average a...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.4355

    authors: Khan R,Ibrahim H,Tulpule S,Iroka N

    更新日期:2016-05-01 00:00:00

  • Clinical implications of insulin-like growth factor II mRNA-binding protein 3 expression in non-small cell lung carcinoma.

    abstract::In order to examine the role of insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression for the prognostic evaluation of non-small cell lung carcinoma (NSCLC), a total of 186 breast cancer patients, with adjacent non-tumor lung tissues, were selected for immunohistochemical staining of IMP3 protein. The...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2015.2910

    authors: Zhang J,Ou Y,Ma Y,Zheng L,Zhang X,Xia R,Kong F,Shen Y,Wang S,Lin L

    更新日期:2015-04-01 00:00:00

  • RhoC is essential in TGF-β1 induced epithelial-mesenchymal transition in cervical cancer cells.

    abstract::Epithelial-mesenchymal transition (EMT) is a critical process in the promotion of epithelial tumor progression and metastasis. The present study aimed to investigate the role of Ras homolog gene family, member C (RhoC) guanosine triphosphatase (GTPase) in transforming growth factor (TGF)-β1 induced EMT. EMT occurred i...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2015.3287

    authors: He X,Qian Y,Cai H,Yang S,Cai J,Wang Z

    更新日期:2015-08-01 00:00:00

  • Expression of CD24 and B7-H3 in breast cancer and the clinical significance.

    abstract::This study aimed to investigate the correlation between the expression of CD24 and B7-H3 in breast cancer tissues and the clinical significance. Expression of CD24 and B7-H3 in breast cancer and adjacent tissues were detected by immunohistochemistry. Quantitative PCR was used to detect the expression of CD24 and B7-H3...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.7142

    authors: Cong F,Yu H,Gao X

    更新日期:2017-12-01 00:00:00

  • Role of exosomes in hepatocellular carcinoma cell mobility alteration.

    abstract::Exosomes have gained increased research focus due to their key roles as messengers. The components of exosomes include proteins and RNAs that may be horizontally transferred between adjacent or distant cells. Hepatocellular carcinoma (HCC) is among the most malignant types of cancer worldwide, with exosomes implicated...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.7257

    authors: Wang S,Chen G,Lin X,Xing X,Cai Z,Liu X,Liu J

    更新日期:2017-12-01 00:00:00

  • A novel FOXA1/ESR1 interacting pathway: A study of Oncomine™ breast cancer microarrays.

    abstract::Forkhead box protein A1 (FOXA1) is essential for the growth and differentiation of breast epithelium, and has a favorable outcome in breast cancer (BC). Elevated FOXA1 expression in BC also facilitates hormone responsiveness in estrogen receptor (ESR)-positive BC. However, the interaction between these two pathways is...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.6329

    authors: Chaudhary S,Krishna BM,Mishra SK

    更新日期:2017-08-01 00:00:00

  • Schwannoma of the colon: A case report and review of the literature.

    abstract::Colonic schwannomas are rare gastrointestinal mesenchymal tumors, and only a limited number of cases has been reported. The occurrence of these tumors is less common in the large intestine than in the stomach. The present study reports a case of colonic schwannoma in a 62-year-old female patient with no specific sympt...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.4271

    authors: Wang WB,Chen WB,Lin JJ,Xu JH,Wang JH,Sheng QS

    更新日期:2016-04-01 00:00:00

  • Clinical value of magnetic resonance imaging in preoperative T staging of gastric cancer and postoperative pathological diagnosis.

    abstract::The aim of the present study was to evaluate the clinical value of magnetic resonance imaging (MRI) in the preoperative T staging of gastric cancer and in the postoperative pathological diagnosis. In total, 30 patients with gastric cancer were investigated, including 19 males and 11 females (age, 50-69 years; mean age...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2014.2135

    authors: Huo X,Yuan K,Shen Y,Li M,Wang Q,Xing L,Shi G

    更新日期:2014-07-01 00:00:00

  • Casticin inhibits epithelial-mesenchymal transition of liver cancer stem cells of the SMMC-7721 cell line through downregulating Twist.

    abstract::The existence of cancer stem cells (CSCs) is central to the pathogenesis and therapeutic target of human hepatocellular carcinoma. The aim of this study was to investigate the effects of casticin on epithelial-mesenchymal transition (EMT) of liver cancer stem cells (LCSCs) derived from the SMMC-7721 cell line. Our res...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2014.1899

    authors: He M,Cao XC,He GC,Sheng XF,Ai XH,Wu YH

    更新日期:2014-05-01 00:00:00

  • MicroRNA-125a-3p downregulation correlates with tumorigenesis and poor prognosis in patients with non-small cell lung cancer.

    abstract::MicroRNA (miR)-125a-3p is derived from the 3'-end of pre-miR-125a, which is associated with several types of cancer, such as gastric and prostate cancer, and glioma. The aim of the present study was to identify the prognostic significance of miR-125a-3p expression levels in patients with NSCLC. The gene expression omn...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.6809

    authors: Hou L,Luo P,Ma Y,Jia C,Yu F,Lv Z,Wu C,Fu D

    更新日期:2017-10-01 00:00:00

  • Association between FOXM1 and hedgehog signaling pathway in human cervical carcinoma by tissue microarray analysis.

    abstract::Forkhead box M1 (FOXM1) and hedgehog (Hh) signaling pathway are implicated in the formation and development of human tumors, including cervical cancer. Previous studies have indicated that FOXM1 may be a downstream target gene of the Hh signaling pathway, but their association in cervical cancer is largely unknown. In...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.4932

    authors: Chen H,Wang J,Yang H,Chen D,Li P

    更新日期:2016-10-01 00:00:00

  • Effect of synchronous solitary bone metastasectomy and lung cancer resection on non-small cell lung cancer patients.

    abstract::Lung cancer is the most frequent cause of cancer-associated mortality among men and women globally. The skeleton is one of the most common metastatic sites. The majority of patients exhibiting bone metastases are treated using systemic therapy or symptom-based palliative approaches without surgery. The present study a...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.4190

    authors: Zhao T,Gao Z,Wu W,He W,Yang YI

    更新日期:2016-03-01 00:00:00

  • A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review).

    abstract::The use of 5α-reductase inhibitors (5α-RIs) as prostate cancer chemoprevention agents is controversial. Two large randomized trials, the Prostate Cancer Prevention Trial (PCPT) and the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Trial, have both shown a decreased incidence of prostate cancer in patient...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2014.2388

    authors: Lacy JM,Kyprianou N

    更新日期:2014-10-01 00:00:00

  • Network analysis of DEGs and verification experiments reveal the notable roles of PTTG1 and MMP9 in lung cancer.

    abstract::Lung cancer, a malignant tumor, is the most frequently fatal cancer, with poor survival rates in the advanced stages. In order to improve the understanding of this disease, and to improve the outcomes of patients, additional studies are required. In the present study, differentially expressed genes (DEGs) in patients ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.7329

    authors: Xu X,Cao L,Zhang Y,Yin Y,Hu X,Cui Y

    更新日期:2018-01-01 00:00:00

  • Original tumour suppressor gene polycystic kidney and hepatic disease 1-like 1 is associated with thyroid cancer cell progression.

    abstract::In recent decades, thyroid cancer (TC) has become one of the most common endocrine malignancies. Next-generation sequencing of paired TC and adjacent healthy thyroid tissues demonstrated that polycystic kidney and hepatic disease 1-like 1 (PKHD1L1) may serve as a tumour suppressor gene in thyroid cancer. However, the ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2019.10632

    authors: Zheng C,Quan R,Xia EJ,Bhandari A,Zhang X

    更新日期:2019-09-01 00:00:00

  • Utilization of lung cancer cell lines for the study of lung cancer stem cells.

    abstract::Lung cancer is one of the most lethal types of cancer, and its poor prognosis is primarily due to drug resistance and cancer recurrence. As it is associated with a low five-year survival rate, lung cancer stem cells (LCSCs) have been the subject of numerous recent studies. For these studies of LCSCs, lung cancer cell ...

    journal_title:Oncology letters

    pub_type: 杂志文章,评审

    doi:10.3892/ol.2018.8265

    authors: Wang Y,Jiang M,Du C,Yu Y,Liu Y,Li M,Luo F

    更新日期:2018-05-01 00:00:00

  • The role of protein p16INK4a in non-oropharyngeal head and neck squamous cell carcinoma in Southern China.

    abstract::Cyclin-dependent kinase inhibitor 2A (p16INK4a) protein is a surrogate immunohistochemical marker of human papillomavirus infection in oropharynx squamous cell carcinoma (OPSCC). However, the effects of p16INK4a in non-OPSCC require additional analysis. In addition, major gaps remain in the literature, including small...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.9353

    authors: Yang H,Cao Y,Li ZM,Li YJ,Jiang WQ,Shi YX

    更新日期:2018-11-01 00:00:00

  • The interaction between RACK1 and WEE1 regulates the growth of gastric cancer cell line HGC27.

    abstract::Receptor of activated C Kinase 1 (RACK1) is an essential scaffold and anchoring protein, which serves an important role in multiple tumorigenesis signaling pathways. The present study aimed to investigate the expression of RACK1 in gastric cancer (GC), and its association with the occurrence and development of GC. In ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.6741

    authors: Liu C,Ren L,Wang Y,Liu Y,Xiao J

    更新日期:2017-10-01 00:00:00

  • Expression of V-domain immunoglobulin suppressor of T cell activation is associated with the advanced stage and presence of lymph node metastasis in ovarian cancer.

    abstract::V-domain immunoglobulin suppressor of T cell activation (VISTA) is a novel negative immune checkpoint that belongs to the B7 family. VISTA is primarily expressed on hematopoietic cells and inhibits T cell proliferation and cytokine production. The blockade of VISTA has demonstrated promising results in certain murine ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.9059

    authors: Liao H,Zhu H,Liu S,Wang H

    更新日期:2018-09-01 00:00:00

  • Non-pegylated liposomal doxorubicin for patients with recurrent ovarian cancer: A multicentric phase II trial.

    abstract::Patients with non-platinum-sensitive recurrent ovarian cancer have a poor prognosis. Non-pegylated liposomal doxorubicin (Myocet®) is a promising drug that may be able to improve treatment for such patients. In the current study, patients with recurrent ovarian cancer relapsing within 12 months after primary treatment...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.4740

    authors: Brucker J,Mayer C,Gebauer G,Mallmann P,Belau AK,Schneeweiss A,Sohn C,Eichbaum M

    更新日期:2016-08-01 00:00:00

  • Immunostaining for thyroid transcription factor 1, Napsin A, p40, and cytokeratin 5 aids in differential diagnosis of non-small cell lung carcinoma.

    abstract::The present study aimed to examine the effectiveness of immunostaining of cytological specimens in discerning squamous from non-squamous cell carcinoma. Various combinations of six antibodies were examined in order to determine the optimal combination for use in differential diagnosis. Immunostaining was performed usi...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2015.3045

    authors: Ikeda S,Naruse K,Nagata C,Kuramochi M,Onuki T,Inagaki M,Suzuki K

    更新日期:2015-05-01 00:00:00

  • Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer.

    abstract::The response of triple-negative breast cancer (TNBC) to chemotherapy is heterogeneous; particular subtype classifications based on mRNA gene expression analysis have been demonstrated to be associated with a pathological complete response (pCR). The aim of the present study was to investigate additional clinical and p...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.6692

    authors: Nakashoji A,Matsui A,Nagayama A,Iwata Y,Sasahara M,Murata Y

    更新日期:2017-10-01 00:00:00

  • Aloe-emodin, an anthraquinone, in vitro inhibits proliferation and induces apoptosis in human colon carcinoma cells.

    abstract::The present study aimed to investigate the anticancer effect of aloe-emodin, an anthraquinone compound present in the leaves of Aloe vera, on two human colon carcinoma cell lines, DLD-1 and WiDr. Colon carcinoma cells were treated with various concentrations of aloe-emodin for different durations. Cell viability was m...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol_00000096

    authors: Lin KY,Uen YH

    更新日期:2010-05-01 00:00:00

  • Aggressive osteoblastoma of the sphenoid bone.

    abstract::For osteoblastoma, with its predilection for the spinal column and appendicular skeleton, the skull is an unusual site, and paranasal sinus involvement is very rare. Herein, we report on a case in which the disease was located within the sphenoid bone. To the best of our knowledge, this is the 4th reported case of ost...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol_00000065

    authors: Kukwa W,Oziębło A,Oecińska A,Czarnecka AM,Włodarski K,Kukwa A

    更新日期:2010-03-01 00:00:00

  • A 20(S)-protopanaxadiol derivative PPD12 reverses ABCB1-mediated multidrug resistance with oral bioavailability and low toxicity.

    abstract::The ATP-binding cassette subfamily B member 1 (ABCB1) is a transporter that mediates multidrug resistance (MDR) against chemotherapy, which leads to decreased patient survival. To inhibit ABCB1 activity in MDR cancer cells, the authors previously designed and synthesized a derivative from 20(S)-protopanaxadiol (PPD) P...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.9338

    authors: Wei S,Chen W,Hu L,Pan J,Wang X

    更新日期:2018-11-01 00:00:00

  • Activating BRAF gene mutations are uncommon in hormone refractory prostate cancer in Caucasian patients.

    abstract::Activating mutations in the cytosolic serine/threonine kinase, BRAF, have been reported in a variety of neoplasms. BRAF activation may contribute to tumor growth via activation of the MAP/ERK kinase pathway, and BRAF represents a possible therapeutic target. Activating BRAF mutations were recently reported in approxim...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol_00000127

    authors: Köllermann J,Albrecht H,Schlomm T,Huland H,Graefen M,Bokemeyer C,Simon R,Sauter G,Wilczak W

    更新日期:2010-07-01 00:00:00

  • Upregulation of ULK1 expression in PC-3 cells following tumor protein P53 transfection by sonoporation.

    abstract::The aim of the present study was to investigate whether ultrasound combined with microbubbles was able to enhance liposome-mediated transfection of genes into human prostate cancer cells, and to examine the association between autophagy and tumor protein P53 (P53). An MTT assay was used to evaluate cell viability, whi...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2015.3946

    authors: Wang YU,Chen YN,Zhang W,Yang YU,Bai WK,Shen E,Hu B

    更新日期:2016-01-01 00:00:00

  • Autophagy activation contributes to glutathione transferase Mu 1-mediated chemoresistance in hepatocellular carcinoma.

    abstract::Glutathione transferase Mu 1 (GSTM1) induces cancer drug resistance by hydrolyzing cancer chemotherapeutics or activating the anti-apoptosis pathway. However, the chemoresistance-inducing mechanism of GSTM1 in hepatocellular carcinoma (HCC) remains unknown. In the present study, the expression of GSTM1 was examined in...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.8667

    authors: Fu XT,Song K,Zhou J,Shi YH,Liu WR,Tian MX,Jin L,Shi GM,Gao Q,Ding ZB,Fan J

    更新日期:2018-07-01 00:00:00

  • BRAF-activated long non-coding RNA contributes to colorectal cancer migration by inducing epithelial-mesenchymal transition.

    abstract::Long non-coding RNAs (lncRNAs) are recently identified regulators in tumorigenesis and tumour progression. BRAF-activated lncRNA (BANCR) is overexpressed in melanoma and has a potential functional role in melanoma cell migration. However, little is known concerning the role of BANCR in the development of colorectal ca...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2014.2154

    authors: Guo Q,Zhao Y,Chen J,Hu J,Wang S,Zhang D,Sun Y

    更新日期:2014-08-01 00:00:00